HIPAA Alert: Potential Data Breach Learn More

Close this search box.
Beata Pieczara, MD

Beata Pieczara, MD

Board Certifications: Hematology, Internal Medicine and Medical Oncology

Languages: English and Polish

Locations: Riverdale, NJ

Dr. Beata Pieczara joins RCCA after several years of practicing in community oncology. She brings her knowledge, experience, and compassion for patients, who are very often facing the most difficult challenge of their life. “I choose medical oncology because it is an extremely gratifying, challenging and ever-changing field of medicine. The relationship with patients and their families which develop during the course of diagnosis and treatment are truly unique. I feel we are becoming gatekeepers of our patients’ care in a very intense way. I am happy to assist with my care to achieve remission or even the cure of cancer. When cure is not possible, extending time and improving quality of life is my goal with all available treatment options.It is my privilege to witness the rise of our patients’ and their families’ resilience and determination to beat their illness. I am always ready to help, encourage and be there whenever they need me.”


Medical education

Medical School of Warsaw, Poland


Bronx Lebanon Hospital/Montefiore Medical Center


New York Medical College, Westchester Medical Center in Valhalla, NY

Awards and honors

Awards and Honors

Castle Connolly Top Doctors

Professional Memberships

American Society of Clinical Oncology and American Society of Hematology

Special Interests

GI, breast neoplasms and hematological conditions

Hospital Affiliations

Chilton Medical Center

we are here for you

For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.

Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.